Search

Your search keyword '"Provine, Nicholas M."' showing total 144 results

Search Constraints

Start Over You searched for: Author "Provine, Nicholas M." Remove constraint Author: "Provine, Nicholas M."
144 results on '"Provine, Nicholas M."'

Search Results

4. Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients

5. A conserved population of MHC II-restricted, innate-like, commensal-reactive T cells in the gut of humans and mice

7. T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

8. Fine needle aspiration of human lymph nodes reveals cell populations and soluble interactors pivotal to immunological priming.

9. Human MAIT Cell Activation In Vitro

11. Development of novel replication-defective lymphocytic choriomeningitis virus vectors expressing SIV antigens

14. Vaccine-elicited CD4 T cells induce immunopathology after chronic LCMV infection

15. Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses

16. A conserved population of MHC II-restricted, innate-like, commensal-reactive T cells in the gut of humans and mice

17. Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses

18. Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity.

19. Evaluation of perturbed iron-homeostasis in a prospective cohort of patients with COVID-19

20. CMV-associated T cell and NK cell terminal differentiation does not affect immunogenicity of ChAdOx1 vaccination

22. Adenovirus vectors activate Vδ2 + γδT cells in a type I interferon‐, TNF‐, and IL‐18‐dependent manner

24. T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

25. MAIT cell activation augments adenovirus vector vaccine immunogenicity

26. Human intestinal tissue-resident memory T cells comprise transcriptionally and functionally distinct subsets

27. Successful treatment of COVID-19 with remdesivir in the absence of humoral immunity

29. Human intestinal tissue-resident memory CD8+ T cells comprise transcriptionally and functionally distinct subsets

30. Identification of immune correlates of fatal outcomes in critically ill COVID-19 patients.

31. Adenovirus vectors activate Vδ2+ γδT cells in a type I interferon‐, TNF‐, and IL‐18‐dependent manner.

32. Unique and Common Features of Innate-Like Human Vδ2+ γδT Cells and Mucosal-Associated Invariant T Cells

33. Activation of MAIT cells plays a critical role in viral vector vaccine immunogenicity

34. Combined HDAC and BET Inhibition Enhances Melanoma Vaccine Immunogenicity and Efficacy

36. Adenovirus vector vaccination reprograms pulmonary fibroblastic niches to support protective inflating memory CD8+T cells

37. Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report.

42. Adenovirus serotype 5 vaccine vectors trigger IL-27–dependent inhibitory CD4 + T cell responses that impair CD8 + T cell function

43. Vaccine-Elicited CD4 T Cells Induce Immunopathology Following Chronic LCMV Infection

44. Immediate Dysfunction of Vaccine-Elicited CD8+ T Cells Primed in the Absence of CD4+ T Cells

46. Adenovirus Serotype 5 Vectors Trigger IL-27-Dependent Inhibitory CD4+ T Cell Responses

Catalog

Books, media, physical & digital resources